FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,643 Cr | ₹3,317 Cr | ₹3,180 Cr | ₹3,038 Cr | ₹2,655 Cr |
What is the latest Total Liabilities ratio of FDC ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,643 Cr |
| Mar2024 | ₹3,317 Cr |
| Mar2023 | ₹3,180 Cr |
| Mar2022 | ₹3,038 Cr |
| Mar2021 | ₹2,655 Cr |
How is Total Liabilities of FDC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,643 Cr | 9.85 | |
| Mar2024 | ₹3,317 Cr | 4.31 | |
| Mar2023 | ₹3,180 Cr | 4.66 | |
| Mar2022 | ₹3,038 Cr | 14.41 | |
| Mar2021 | ₹2,655 Cr | - | |
Compare Total Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,652.8 Cr | -4.1% | -8.5% | -21.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,477.0 Cr | 2.5% | 4% | -3.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,934.0 Cr | -1% | 0.5% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,469.0 Cr | 6.9% | 8.7% | 21% | Stock Analytics | |
| CIPLA | ₹123,250.0 Cr | 1.4% | -2.4% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,038.0 Cr | 2.4% | -2.2% | -4.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -4.1% |
-8.5% |
-21.5% |
| SENSEX | 1.4% |
2.4% |
5.1% |
You may also like the below Video Courses